Matches in Wikidata for { <http://www.wikidata.org/entity/Q59504330> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q59504330 description "article scientifique publié en 2016" @default.
- Q59504330 description "im August 2016 veröffentlichter wissenschaftlicher Artikel" @default.
- Q59504330 description "wetenschappelijk artikel" @default.
- Q59504330 description "наукова стаття, опублікована в серпні 2016" @default.
- Q59504330 name "Transient decrease of hepatic NAD+ and amino acid alterations during treatment with valproate: new insights on drug-induced effects in vivo using targeted MS-based metabolomics" @default.
- Q59504330 name "Transient decrease of hepatic NAD+ and amino acid alterations during treatment with valproate: new insights on drug-induced effects in vivo using targeted MS-based metabolomics" @default.
- Q59504330 type Item @default.
- Q59504330 label "Transient decrease of hepatic NAD+ and amino acid alterations during treatment with valproate: new insights on drug-induced effects in vivo using targeted MS-based metabolomics" @default.
- Q59504330 label "Transient decrease of hepatic NAD+ and amino acid alterations during treatment with valproate: new insights on drug-induced effects in vivo using targeted MS-based metabolomics" @default.
- Q59504330 prefLabel "Transient decrease of hepatic NAD+ and amino acid alterations during treatment with valproate: new insights on drug-induced effects in vivo using targeted MS-based metabolomics" @default.
- Q59504330 prefLabel "Transient decrease of hepatic NAD+ and amino acid alterations during treatment with valproate: new insights on drug-induced effects in vivo using targeted MS-based metabolomics" @default.
- Q59504330 P1433 Q59504330-191E2106-3383-4434-B56E-F09A986EAB74 @default.
- Q59504330 P1476 Q59504330-01D702D4-03B4-4E8B-9C6F-637744C83527 @default.
- Q59504330 P2093 Q59504330-05666EC7-EECF-4BEE-B153-7C0FA6B46AD4 @default.
- Q59504330 P2093 Q59504330-2BCD4952-D074-4692-AE68-6B1F92A7710A @default.
- Q59504330 P2093 Q59504330-37C6D5B8-7A65-4978-89BD-9B70B53D56B9 @default.
- Q59504330 P2093 Q59504330-5429BD0D-8FA9-41B5-A6AD-AB94B51DFADE @default.
- Q59504330 P2093 Q59504330-AD8B3274-E173-4564-8FD6-D08F772469A3 @default.
- Q59504330 P2093 Q59504330-CEBD8BE8-BFD6-4955-A309-A9102432DF9C @default.
- Q59504330 P2860 Q59504330-A384FA41-1B48-446F-9281-159BE91FD9F8 @default.
- Q59504330 P2888 Q59504330-D0FDB620-B217-453E-8AD4-C05B67D664DA @default.
- Q59504330 P31 Q59504330-4E9F6055-2114-483C-90A1-BF25EB2FDC2F @default.
- Q59504330 P356 Q59504330-C66AE612-2409-4348-B255-6D76F8C812D6 @default.
- Q59504330 P433 Q59504330-A6E0B34F-B3F1-4F56-B7B6-AFCE02AE7368 @default.
- Q59504330 P478 Q59504330-F9003114-D35C-426C-8B15-74740C859575 @default.
- Q59504330 P50 Q59504330-EAE23EDB-CE2D-4F4E-8BAC-095764026327 @default.
- Q59504330 P50 Q59504330-F5EFE255-225D-4D11-92CC-5DFC2227AE65 @default.
- Q59504330 P577 Q59504330-1BFB4CBF-F737-4557-B832-6992BCAB8A5A @default.
- Q59504330 P921 Q59504330-767B3661-C783-4E99-976F-BF8EEDC9B853 @default.
- Q59504330 P356 S11306-016-1091-9 @default.
- Q59504330 P1433 Q15764355 @default.
- Q59504330 P1476 "Transient decrease of hepatic NAD+ and amino acid alterations during treatment with valproate: new insights on drug-induced effects in vivo using targeted MS-based metabolomics" @default.
- Q59504330 P2093 "Arno G. van Cruchten" @default.
- Q59504330 P2093 "Lodewijk IJlst" @default.
- Q59504330 P2093 "Luísa Diogo" @default.
- Q59504330 P2093 "Marco F. Moedas" @default.
- Q59504330 P2093 "Margarida F. B. Silva" @default.
- Q59504330 P2093 "Wim Kulik" @default.
- Q59504330 P2860 Q42935249 @default.
- Q59504330 P2888 s11306-016-1091-9 @default.
- Q59504330 P31 Q13442814 @default.
- Q59504330 P356 "10.1007/S11306-016-1091-9" @default.
- Q59504330 P433 "8" @default.
- Q59504330 P478 "12" @default.
- Q59504330 P50 Q42846193 @default.
- Q59504330 P50 Q87619350 @default.
- Q59504330 P577 "2016-08-01T00:00:00Z" @default.
- Q59504330 P921 Q12149006 @default.